Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Mazdutide

PRIME

Innovent · Phase 4 · Recruiting · Enrollment 60

NCT07718126

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
GLP-1/GCG receptor dual agonist plus lifestyle optimization (GG Group)n/rn/rn/rn/r
Lifestyle optimization only (LL group)n/rn/rn/rn/r

Not shown

  • GLP-1/GCG receptor dual agonist plus lifestyle optimization (GG Group): endpoint not reported
  • Lifestyle optimization only (LL group): endpoint not reported